TrialJournal of diabetes investigation2020

Efficacy and safety of metformin and sitagliptin-based dual and triple therapy in elderly Chinese patients with type 2 diabetes: Subgroup analysis of STRATEGY study.

Xiangyang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.